TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
Titel:
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
Auteur:
Thielmann, Carl M. Matull, Johanna Zaremba, Anne Murali, Rajmohan Chorti, Eleftheria Lodde, Georg Jansen, Philipp Herbst, Rudolf Terheyden, Patrick Utikal, Jochen Pföhler, Claudia Ulrich, Jens Kreuter, Alexander Mohr, Peter Gutzmer, Ralf Meier, Friedegund Dippel, Edgar Weichenthal, Michael Kretz, Julia Möller, Inga Sucker, Antje Paschen, Annette Livingstone, Elisabeth Zimmer, Lisa Hadaschik, Eva Ugurel, Selma Schadendorf, Dirk Griewank, Klaus G.